Meta Pixel

Company Updates

Company Updates
YPB First Commercial Contract in Mexico

24th August 2016, ASX Announcement Brand Protection and Customer Engagement solutions company YPB Group Limited (ASX: YPB) has secured its first commercial contract in Mexico through its joint venture (JV) with Affyrmx Group. The initial contract value is US$130,000, with YPB’s proprietary tracer solution to be used to PROTECT redeemable food coupons that are frequently […]

Company Updates
Craig Farrow Joins Bulletproof Board

24th August 2016, ASX Announcement Bulletproof Group Limited (ASX:BPF) welcomes Craig Farrow to the board as a non-executive director, effective today. Mr. Farrow has also accepted the role as chair of the Audit and Risk Committee. Mr. Farrow is a Fellow of Chartered Accountants Australia New Zealand (CAANZ), Australian Institute of Company Directors (AICD) and […]

Company Updates
Proteomics International Expands Diagnostics Portfolio to Endometriosis

24th August 2016, ASX Announcement Life sciences company Proteomics International Laboratories Ltd (PILL, ASX: PIQ) is applying its disruptive proteomics technology platform to new areas of significant unmet medical need. PILL is investigating protein ‘fingerprints’ that can diagnose endometriosis from a simple blood test. Endometriosis affects one in ten women in their reproductive years and […]

Company Updates
Altech Receives Loan Indicative Terms and Conditions

24th August 2016, ASX Announcement Highlights Altech receives lenders first draft indicative term sheet Altech targeting total project debt of US$70 million Export credit cover (ECA) component of US$60 million Sole lender structure proposed for the entire debt portion of up to US$70 million Simplified debt financing and attractive ECA-covered component Altech Chemicals Limited (Altech/the […]

Company Updates
Anti-Cancer Drug Discovered in Rainforest Successfully Tested on Humans

22nd August 2016, The Cairns Post by Daniel Bateman A POTENTIAL cancer cure discovered in Far North Queensland that has been successfully tested on human patients is hoped to become commercially available in four years. Brisbane-based researchers QBiotics have released the ­results of their first clinical trials of the drug EBC-46. The drug has been […]

Join over 45,000+ sophisticated investors

Join Now